Search research articles
Contact Us
Filters
Showing results (11-20 of 73) with videos related to
Page
of 8
Sort By:
Toxicology and Applied Pharmacology
|
May 24, 2012
Nonclinical safety strategies for stem cell therapies
Michaela E Sharpe, Daniel Morton, Annamaria Rossi
Toxicologic Pathology
|
October 19, 2012
Improving carcinogenicity assessment
Daniel Morton, Todd Bourcier, Carl L Alden
Toxicologic Pathology
|
March 12, 2014
Perspectives on drug-induced vascular injury
Daniel Morton, Christopher D Houle, Lindsay Tomlinson
Toxicologic Pathology
|
February 4, 2014
Injection-site malignant fibrous histiocytomas in a pegvisomant carcinogenicity study in SD rats
Phillip M Bartholomew, John M Kreeger, Daniel Morton
International Journal of Radiation Oncology, Biology, Physics
|
March 30, 2016
Seed Placement in Permanent Breast Seed Implant Brachytherapy: Are Concerns Over Accuracy Valid?
Daniel Morton, Michelle Hilts, Deidre Batchelar, et al.
Toxicologic Pathology
|
February 14, 2012
Spontaneous tumor incidence in rasH2 mice: review of internal data and published literature
Prashant R Nambiar, Susan E Turnquist, Daniel Morton
Toxicologic Pathology
|
May 10, 2008
Spontaneous and age-related testicular findings in beagle dogs
Michael J Goedken, Roy L Kerlin, Daniel Morton
Organic Letters
|
July 2, 2004
A convenient synthesis of chiral nonracemic vinyl aziridines
Daniel Morton, David Pearson, Robert A Field, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
April 27, 2007
Desymmetrisation of a centrosymmetric molecule by carbon-carbon bond formation: asymmetric aldol reactions of a centrosymmetric dialdehyde
Karen Dodd, Daniel Morton, Stephen Worden, et al.
Chemical Communications (Cambridge, England)
|
April 20, 2006
Direct synthesis of chiral aziridines from N-tert-butyl-sulfinylketimines
Daniel Morton, David Pearson, Robert A Field, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 73) with videos related to
Sort By:
Page
of 8
Toxicology and Applied Pharmacology
|
May 24, 2012
Nonclinical safety strategies for stem cell therapies
Michaela E Sharpe, Daniel Morton, Annamaria Rossi
Toxicologic Pathology
|
October 19, 2012
Improving carcinogenicity assessment
Daniel Morton, Todd Bourcier, Carl L Alden
Toxicologic Pathology
|
March 12, 2014
Perspectives on drug-induced vascular injury
Daniel Morton, Christopher D Houle, Lindsay Tomlinson
Toxicologic Pathology
|
February 4, 2014
Injection-site malignant fibrous histiocytomas in a pegvisomant carcinogenicity study in SD rats
Phillip M Bartholomew, John M Kreeger, Daniel Morton
International Journal of Radiation Oncology, Biology, Physics
|
March 30, 2016
Seed Placement in Permanent Breast Seed Implant Brachytherapy: Are Concerns Over Accuracy Valid?
Daniel Morton, Michelle Hilts, Deidre Batchelar, et al.
Toxicologic Pathology
|
February 14, 2012
Spontaneous tumor incidence in rasH2 mice: review of internal data and published literature
Prashant R Nambiar, Susan E Turnquist, Daniel Morton
Toxicologic Pathology
|
May 10, 2008
Spontaneous and age-related testicular findings in beagle dogs
Michael J Goedken, Roy L Kerlin, Daniel Morton
Organic Letters
|
July 2, 2004
A convenient synthesis of chiral nonracemic vinyl aziridines
Daniel Morton, David Pearson, Robert A Field, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
April 27, 2007
Desymmetrisation of a centrosymmetric molecule by carbon-carbon bond formation: asymmetric aldol reactions of a centrosymmetric dialdehyde
Karen Dodd, Daniel Morton, Stephen Worden, et al.
Chemical Communications (Cambridge, England)
|
April 20, 2006
Direct synthesis of chiral aziridines from N-tert-butyl-sulfinylketimines
Daniel Morton, David Pearson, Robert A Field, et al.
Page
of 8